Holen Sie sich die Stockscreener-App
5.8077
5.06%
-0.3223
Schlusskurs vom Vortag:
$6.13
Offen:
$6.21
24-Stunden-Volumen:
125.12K
Relative Volume:
0.20
Marktkapitalisierung:
$366.71M
Einnahmen:
$2.72M
Nettoeinkommen (Verlust:
$-85.08M
KGV:
-3.0092
EPS:
-1.93
Netto-Cashflow:
$-70.93M
1W Leistung:
-2.84%
1M Leistung:
+50.78%
6M Leistung:
+203.13%
1J Leistung:
+380.99%
1-Tages-Spanne:
$5.75
$6.25
1-Wochen-Bereich:
$5.56
$6.25
52-Wochen-Spanne:
$0.6922
$6.25
Shattuck Labs Inc Stock (STTK) Company Profile
Firmenname
Shattuck Labs Inc
Sektor
Branche
Telefon
512-900-4690
Adresse
500 W. 5TH STREET, AUSTIN
Compare STTK vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
5.795 | 387.91M | 2.72M | -85.08M | -70.93M | -1.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.80 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.16 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
696.52 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.65 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.37 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Fortgesetzt | Needham | Buy |
| 2026-01-28 | Eingeleitet | Piper Sandler | Overweight |
| 2025-12-01 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-09-08 | Eingeleitet | Wedbush | Outperform |
| 2025-03-17 | Eingeleitet | Leerink Partners | Outperform |
| 2024-10-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-10-02 | Herabstufung | Needham | Buy → Hold |
| 2024-10-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-08-31 | Eingeleitet | BTIG Research | Buy |
| 2022-06-01 | Eingeleitet | Citigroup | Buy |
| 2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-14 | Eingeleitet | Berenberg | Buy |
| 2021-01-11 | Eingeleitet | Evercore ISI | Outperform |
| 2020-11-03 | Eingeleitet | Citigroup | Buy |
| 2020-11-03 | Eingeleitet | Cowen | Outperform |
| 2020-11-03 | Eingeleitet | Needham | Buy |
Alle ansehen
Shattuck Labs Inc Aktie (STTK) Neueste Nachrichten
Will Shattuck Labs Inc benefit from green energy policies2026 PreEarnings & Expert Approved Trade Ideas - baoquankhu1.vn
Shattuck Labs, Inc. (NASDAQ:STTK) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Shattuck Labs (NASDAQ:STTK) Coverage Initiated at Needham & Company LLC - Defense World
Volume Recap: Will Shattuck Labs Inc benefit from green energy policies2025 Sector Review & AI Enhanced Trading Alerts - baoquankhu1.vn
Portfolio Shifts: Is Shattuck Labs Inc stock a value trapBuy Signal & Short-Term High Return Ideas - baoquankhu1.vn
Flagship-backed Generate Biomedicines shares fall 6% in Nasdaq debut - AOL.com
Why Shattuck Labs Stock Soared More Than 53% Higher This Week - Nasdaq
Shattuck Labs, Inc. Hits New 52-Week High of $5.19 - Markets Mojo
Needham & Company LLC Begins Coverage on Shattuck Labs (NASDAQ:STTK) - MarketBeat
STTK: Wedbush Raises Price Target, Maintains Outperform Rating | - GuruFocus
Shattuck Labs stock maintained at Buy by TD Cowen on drug data - Investing.com Canada
Shattuck Labs (NASDAQ:STTK) Price Target Raised to $8.00 at Wedbush - MarketBeat
Shattuck Labs (STTK) Receives Buy Rating with $14 Target - GuruFocus
Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights - Investing News Network
Shattuck Labs (STTK) Anticipates Strong Cash Runway Through 2029 - GuruFocus
Shattuck Labs (STTK) Reports Q4 Revenue and Clinical Trial Progr - GuruFocus
Shattuck Labs 10-K: $1.0M Revenue, $(0.70) EPS on FY Loss Improvement - TradingView
STTK: Net loss improved to $48.8M in 2025 as focus shifted to DR3 platform and cash runway extended into 2029 - TradingView
Shattuck Labs Q4 net loss narrows on lower R&D spend - TradingView
Shattuck Labs (NASDAQ: STTK) cuts 2025 R&D spend, funds operations into 2029 - Stock Titan
Shattuck Labs, Inc. (NASDAQ:STTK) Short Interest Down 14.7% in February - MarketBeat
STTK Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Shattuck Labs at TD Cowen Conference: Strategic Insights in IBD Treatment - Investing.com Canada
Aug PreEarnings: Will Shattuck Labs Inc benefit from sector rotation2025 AllTime Highs & High Conviction Buy Zone Alerts - baoquankhu1.vn
STTK Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
STTK Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Shattuck Labs Announces Participation in Upcoming March Investor Conferences - Investing News Network
Shattuck Labs CEO heads to Boston and Miami for March investor talks - Stock Titan
STTKShattuck Labs, Inc. Latest Stock News & Market Updates - Stock Titan
Here's Why Grail Stock Crashed 50% Today - AOL.com
Shattuck Labs Just Shocked Wall Street: Is STTK the Next Sleeper Biotech Rocket or Total Trap? - AD HOC NEWS
Shattuck Labs, Inc. (NASDAQ:STTK) Receives $6.20 Average Price Target from Analysts - Defense World
Market Recap: Is Shattuck Labs Inc. stock positioned well for digital economyCEO Change & Smart Money Movement Tracker - mfd.ru
Can Shattuck Labs Inc. deliver consistent dividendsPortfolio Return Summary & Free Expert Approved Momentum Trade Ideas - mfd.ru
What’s the RSI of Shattuck Labs Inc. stockWeekly Profit Recap & Free Fast Entry Momentum Trade Alerts - mfd.ru
What is the cash position of Shattuck Labs Inc.July 2025 Weekly Recap & Weekly High Momentum Picks - mfd.ru
Shattuck Labs, Inc. (NASDAQ:STTK) Given Average Rating of "Hold" by Brokerages - MarketBeat
Why is Shattuck Labs Inc. stock going downTrade Entry Summary & Fast Momentum Entry Tips - mfd.ru
Is Shattuck Labs Inc.’s ROIC above industry averageQuarterly Portfolio Review & Weekly Top Gainers Trade List - mfd.ru
Fed Watch: Will Shattuck Labs Inc benefit from green energy policiesEarnings Miss & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium - marketscreener.com
Breakout Zone: Why is Shattuck Labs Inc stock going downAnalyst Downgrade & Advanced Technical Analysis Signals - baoquankhu1.vn
Shattuck Labs to Participate in Immunology Symposium - Intellectia AI
Inside Shattuck Labs' Piper Sandler immunology fireside chat - stocktitan.net
Shattuck Labs Insider Buyers Net US$637k Despite 12% Stock Decline - simplywall.st
Shattuck Labs Sets Earlier Date for 2026 Annual Meeting - TipRanks
Shattuck Labs, Inc. (NASDAQ:STTK) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Shattuck Labs (STTK) Price Target Increased by 55.36% to 7.40 - Nasdaq
Shattuck Labs, Inc. (NASDAQ:STTK) Sees Significant Increase in Short Interest - MarketBeat
Piper Sandler Initiates Coverage of Shattuck Labs (STTK) with Overweight Recommendation - Nasdaq
Piper Sandler Initiates Coverage on STTK with Overweight Rating - GuruFocus
Finanzdaten der Shattuck Labs Inc-Aktie (STTK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Shattuck Labs Inc-Aktie (STTK) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ashiya Mona | Director |
Aug 25 '25 |
Buy |
0.87 |
6,306,127 |
5,471,826 |
5,255,106 |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):